Tenax Therapeutics

Nasdaq: TENX · SEC EDGAR filings

Results on file1
Average 24h move−89.29%across 1 result with a complete 24h price
1 resultTenax Therapeutics
Missed endpoint

TNX-103

Phase 3 n=230 Pulmonary Hypertension

Tenax Therapeutics TENX

24h stock move −89.29%

For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.